BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
NCT06793332
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
39
Enrollment
OTHER
Sponsor class
Conditions
Triple-Negative Breast Cancer (TNBC)
Brain Metastases
Interventions
DRUG:
Ivonescimab Combined With TROP2 ADC
Sponsor
Fudan University